TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/17/21 18:05 | 2/17/21 | CDAK | Codiak Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Morrison Briggs | MA | D | P | 100 | 21.00 | 0 | 5 | New | 5 | D | |||||||||||||||
6/25/20 17:57 | 6/23/20 | RPTX | Repare Therapeutics Inc. | Z4 | Health | Drug | Pharmaceutical Preparations | Morrison Briggs | A8 | D | P | 96 | 20.00 | 0 | 5 | New | 5 | D | |||||||||||||||
3/25/20 16:45 | 3/24/20 | ARVN | Arvinas, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Morrison Briggs | CT | D | P | 95 | 38.18 | 0 | 3 | 9 | 30 | D | |||||||||||||||
2/5/20 16:07 | 2/4/20 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Morrison Briggs | MA | DO | CEO | P | 100 | 8.00 | 0 | 13 | 40 | 44 | D | ||||||||||||||
10/11/19 06:33 | 10/10/19 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Morrison Briggs | MA | DO | CEO | P | 59 | 5.40 | 0 | 11 | 54 | 31 | D | ||||||||||||||
5/13/19 16:11 | 5/9/19 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Morrison Briggs | MA | DO | CEO | P.m | 152 | 7.46 | 0 | 20 | New | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |